NuCana
NCNA
13 hedge funds and large institutions have $159M invested in NuCana in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 4 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
13% less funds holding
Funds holding: 15 → 13 (-2)
21% less capital invested
Capital invested by funds: $200M → $159M (-$41.3M)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$28.4M |
| 2 |
WIM
Woodford Investment Management
London,
United Kingdom
|
+$23M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$975K |
| 4 |
AA
ALPS Advisors
Denver,
Colorado
|
+$355K |
| 5 |
MWNA
Marshall Wace North America
New York
|
+$177K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Prelude Capital Management
New York
|
-$979K |
| 2 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
-$709K |
| 3 |
UBS AM
Chicago,
Illinois
|
-$266K |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$254K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$249K |
NCNA Hedge Fund Activity: Q4 2018 in Review
13 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in NuCana (NCNA) for Q4 2018, worth a combined $159M — down 21% from $200M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NCNA and 2 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 4 added.
The largest buyer was Sofinnova Investments, adding an estimated $28.4M. The largest seller was Prelude Capital Management, exiting entirely with an estimated $979K sold.
- 13 institutional investors held NuCana (NCNA) as of Q4 2018, down from 15 in Q3 2018.
- Funds reported $159M of NuCana stock for Q4 2018, down 21% quarter-over-quarter.
- 2 funds opened new NuCana positions in Q4 2018 and 4 closed out, a net change of -2 holders.
- The largest NuCana buyer in Q4 2018 was Sofinnova Investments, an estimated $28.4M added.
- The largest NuCana seller in Q4 2018 was Prelude Capital Management, an estimated $979K sold.
Based on aggregated 13F filings for Q4 2018.